Pazopanib or sunitinib for metastatic renal-cell carcinoma?

被引：0
|
作者：
Bennet, Neil
机构：
来源：
LANCET ONCOLOGY | 2013年 / 14卷 / 11期
关键词：
D O I：
10.1016/S1470-2045(13)70409-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E442 / E442
页数：1
相关论文
共 50 条
  • [1] Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Cella, David
    Reeves, James
    Hawkins, Robert
    Guo, Jun
    Nathan, Paul
    Staehler, Michael
    de Souza, Paul
    Merchan, Jaime R.
    Boleti, Ekaterini
    Fife, Kate
    Jin, Jie
    Jones, Robert
    Uemura, Hirotsugu
    De Giorgi, Ugo
    Harmenberg, Ulrika
    Wang, Jinwan
    Sternberg, Cora N.
    Deen, Keith
    McCann, Lauren
    Hackshaw, Michelle D.
    Crescenzo, Rocco
    Pandite, Lini N.
    Choueiri, Toni K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08): : 722 - 731
  • [2] Re: Pazopanib Versus Sunitinib in Metastatic Renal-cell Carcinoma
    Sun, Maxine
    Quoc-Dien Trinh
    Perrotte, Paul
    Karakiewicz, Pierre I.
    EUROPEAN UROLOGY, 2014, 65 (05) : 1014 - 1015
  • [3] Re: Pazopanib Versus Sunitinib in Metastatic Renal-cell Carcinoma
    Ouzaid, Idir
    Rini, Brian
    EUROPEAN UROLOGY, 2014, 65 (03) : 667 - 668
  • [4] Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib
    Motzer, Robert J.
    Hutson, Thomas E.
    McCann, Lauren
    Deen, Keith
    Choueiri, Toni K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (18): : 1769 - 1770
  • [5] THE EFFECTS OF PAZOPANIB VERSUS SUNITINIB ON RENAL OUTCOME IN METASTATIC RENAL CELL CARCINOMA
    Lee, Eun Jeong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 561 - 561
  • [6] Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma
    Rautiola, Juhana
    Utriainen, Tapio
    Peltola, Katriina
    Joensuu, Heikki
    Bono, Petri
    ACTA ONCOLOGICA, 2014, 53 (01) : 113 - 118
  • [7] GENETIC POLYMORPHISMS AND SUNITINIB TOXICITY IN METASTATIC RENAL-CELL CARCINOMA
    Sepulveda Sanchez, J.
    Farfan, C.
    Villacampa, F.
    Velasco, G.
    Benitez, J.
    Rodriguez, C.
    Calderon, M.
    Canamares, I.
    Cortes-Funes, H.
    Castellano, D. E.
    ANNALS OF ONCOLOGY, 2012, 23 : 281 - 282
  • [8] Sunitinib versus interferon - alfa in metastatic renal-cell carcinoma
    Irani, Jacques
    PROGRES EN UROLOGIE, 2007, 17 (05): : 996 - 996
  • [9] Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
    Mejean, A.
    Ravaud, A.
    Thezenas, S.
    Colas, S.
    Beauval, J. -B.
    Bensalah, K.
    Geoffrois, L.
    Thiery-Vuillemin, A.
    Cormier, L.
    Lang, H.
    Guy, L.
    Gravis, G.
    Rolland, F.
    Linassier, C.
    Lechevallier, E.
    Beisland, C.
    Aitchison, M.
    Oudard, S.
    Patard, J. -J.
    Theodore, C.
    Chevreau, C.
    Laguerre, B.
    Hubert, J.
    Gross-Goupil, M.
    Bernhard, J. -C.
    Albiges, L.
    Timsit, M. -O.
    Lebret, T.
    Escudier, B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (05): : 417 - 427
  • [10] Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Tomczak, Piotr
    Michaelson, M. Dror
    Bukowski, Ronald M.
    Rixe, Olivier
    Oudard, Stephane
    Negrier, Sylvie
    Szczylik, Cezary
    Kim, Sindy T.
    Chen, Isan
    Bycott, Paul W.
    Baum, Charles M.
    Figlin, Robert A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02): : 115 - 124
12345